Dr. Nagaraju has helped lead international efforts to build standard operating procedures (SOPs) to enable robust pre-clinical trials, where data can be reliably compared across studies (http://www.treat-nmd.eu/research/preclinical/overview/ ).  He has also served on the TREAT-NMD TACT Core Committee, providing advice and guidance on pre-clinical trial design, conduct and data interpretation.

Dr. Nagaraju and the AGADA team will work with your drug development team to design and implement a pre-clinical studies package that will aid in de-risking your program, enabling comparisons across multiple endpoints and benchmarking to comparative studies.